Browsing Over 400 Presentations
Sort By
Opening and welcome
Opening and welcome
Introduction to ESMO
Lecture Time
13:35 - 13:40
Presenter
- Solange Peters (CH)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
13:30 - 13:45
Authors
- Solange Peters (CH)
Opening and welcome
Opening and welcome
Welcome to the Congress
Lecture Time
13:30 - 13:35
Presenter
- Maurice Perol (FR)
- Luis Paz-Ares (ES)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
13:30 - 13:45
Authors
- Maurice Perol (FR)
- Luis Paz-Ares (ES)
Opening and welcome
Opening and welcome
Introduction to IASLC
Lecture Time
13:40 - 13:45
Presenter
- Giorgio Scagliotti (IT)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
13:30 - 13:45
Authors
- Giorgio Scagliotti (IT)
Opening and welcome
Opening and welcome
2018 HHH Award Winner Introduction
Lecture Time
13:45 - 13:45
Presenter
- Solange Peters (CH)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
13:30 - 13:45
Authors
- Solange Peters (CH)
HHH Award Keynote Lecture
Keynote Lecture
The power of the multiple H
Lecture Time
13:45 - 14:15
Presenter
- Fabrice Barlesi (FR)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
13:45 - 14:15
Authors
- Fabrice Barlesi (FR)
First line for oncogene addicted lung cancer
Educational session
The role of first-line combination therapy for oncogene addicted lung cancer
Lecture Time
15:30 - 15:50
Presenter
- Takashi Seto (JP)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Takashi Seto (JP)
Combined treatment stage III
Educational session
Immunotherapy in the stage III paradigm: Rationale and clinical data
Lecture Time
15:30 - 15:50
Presenter
- Solange Peters (CH)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Solange Peters (CH)
First line for oncogene addicted lung cancer
Educational session
First vs second vs third generation EGFR TKI
Lecture Time
14:50 - 15:10
Presenter
- Juergen Wolf (DE)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Juergen Wolf (DE)
Combined treatment stage III
Educational session
Are current NTCP models useful for predicting radiation-induced toxicity?
Lecture Time
14:50 - 15:10
Presenter
- Dirk De Ruysscher (NL)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Dirk De Ruysscher (NL)
First line for oncogene addicted lung cancer
Educational session
Q&A
Lecture Time
15:50 - 16:00
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Combined treatment stage III
Educational session
Q&A
Lecture Time
15:50 - 16:00
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
First line for oncogene addicted lung cancer
Educational session
Key factors that determine the selection of first-line ALK inhibtiors
Lecture Time
15:10 - 15:30
Presenter
- Fiona H. Blackhall (GB)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Fiona H. Blackhall (GB)